SmartTRAK takes a quick look at recent trends that may influence the Total Joints Market in the near and long term

Wall Street Analysts recently called out two trends specifically that could influence the Total Joints Market. One trend, the strengthening of the US dollar, is likely to impact the global market in 2024. Another trend is the increased prescribing of GLP-1 drugs, such as Ozempic, Wegovy, Byetta and Mounjaro, medications first used to treat Type 2 diabetes, as a treatment for obesity. This has the potential to impact the market down the road. In this downloadable article, SmartTRAK maps out the potential impact of these trends.

To download and read the complete article by SmartTRAK's Lisa Mahan, Product Development & IT, Sr. Analyst TJ&E, just click the button below.

In a joint interview with Eugene Malinskiy, founder and CEO of Lazurite, and orthopedic surgeon Dr James Voos, we discuss the world’s first wireless surgical camera, the Lazurite ArthroFree camera.

Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos discuss the technological and clinical benefits of the new ArthroFree camera, the world’s first fully wireless surgical camera, with Andy Knapik, SmartTRAK's Senior Analyst, Soft Tissue & Arthroscopic Technologies.

To learn more about Lazurite and the ArthroFree System, click the following video to watch the interview (27:05 min).  For more details, interview topics by timecode are provided below. To download a complete transcript of the interview, click here.

Interview Topics By Timecode

1:25 Background of Lazurite and the ArthroFree camera.

7:05 Surgeon impressions of the ArthroFree camera.

10:10 Camera integration, image quality, battery life, ergonomics.

16:05 How the camera connects to the monitor and image capture.

19:22 How do facilities react to purchasing the ArthroFree.

22:05 Uses of the ArthroFree camera.

To download the complete transcript of the interview with Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos, just click the button below.

• Complete Q123 Trauma Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Trauma Companies' News, Revenues, Data, Charts and Market Shares
• IM Nailing Closes the Quarter on High with Solid Returns
• New Regulatory Clearances Propel the Pediatric Trauma Segment:
  • OrthoPediatrics
  • NuVasive Specialized Orthopedics, Inc.
  • Wishbone Medical
• Q123 Trauma Regulatory Highlights

During Q1, the Pediatric Trauma segment experienced a notable surge in regulatory clearances, indicating forthcoming product launches aimed at bolstering the segment's growth. These approvals signal  ...

Read the entire Q123 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Spine Market Recap* are:

• Complete Q123 Spine Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Spine Companies' News, Revenues, Data, Charts and Market Shares
• Top Players' Performance
  •  JNJ/DePuy Synthes
  • Globus 
  • NuVasive 
  • Stryker
• Q123 Spine Trends
  • M&A Activity
  • New Products
  • Reimbursement Dynamics
• Regulatory Highlights
• Europe Regulatory Updates
• Clinical Study Progress

Orthofix and SeaSpine announced the completion of its merger in Q123 in which SeaSpine became a wholly owned subsidiary of Orthofix. In a recent note, Canaccord Genuity highlighted SeaSpine, 7D Surgical and Simplify as the most notable of the recent spine acquisitions. SmartTRAK agrees and notes that ...

Read the entire Q123 Spine Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Continued strength in ortho robotics placements and a crowd of new product launches in Q123 set the stage for growth in the remainder of the year.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Ortho Enabling Tech Market Recap* are:

• Complete Q123 Otho Enabling Tech Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All US Ortho Enabling Tech Companies' News, Revenues, Data, Charts and Market Shares
• Robust Q123 Robotics Performances by Company
  
  • Stryker
  • Zimmer Biomet
  • Smith+Nephew
  • JNJ/Depuy Synthes
• New Product Introductions
  
  • Robotics and Ecosystem Launches
  • Navigation and Planning Innovations
• SmartTRAK's Selected Highlights from Q123 Conferences
  
  • JP Morgan 41st Annual Healthcare Conference
  • Canaccord Genuity 2023 Musculoskeletal Conference
  • AAOS 2023 Annual Meeting

In an International Society for Technology in Arthroplasty (ISTA) presentation at the American Academy of Orthopaedic Surgeons 2023 (AAOS 2023) Annual Meeting, President, Digital, Robotics and Enabling Technology at SYK Robert Cohen discussed innovations including a fully connected operating room for a common user experience with planning and mixed-reality guidance combined with robotics and data transfer capabilities. Enabling technology continues to see adoption and integration in orthopedics and with it, the introduction of ...

Read the entire Q123 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

New SaaS technology offering delivers competitive advantage in rapidly changing Ambulatory Surgery Center market.

SmartTRAK, the leading global Medtech business and market software intelligence solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, is pleased to announce the release of ASC Insights, the industry’s first-ever commercially available platform-based solution for the growing Ambulatory Surgery Center (ASC) market. ASC Insights provides real-time insights and rich data to help clients better understand market trends and accelerate commercial growth strategies.

In recent years, the Orthopedic ASC market, valued at over $10 billion, has undergone a significant transition as surgeries increasingly shift from traditional inpatient settings to outpatient ASCs. This shift necessitates that Medtech companies explore new ways to stay informed about myriad data sources and market shifts to drive their commercial growth strategies.

The ASC Insights offering is an extension of the SmartTRAK platform, encompassing comprehensive market analyses and proprietary qualitative insights on trends, as well as readily extractable quantitative metrics. Alternatively, enterprise customers can seamlessly integrate these metrics into their business intelligence platforms. Subscribers to SmartTRAK ASC Insights gain access to a historical news archive, recaps of changes in key facility ownership and information on technologies and reimbursement. Furthermore, customers receive valuable Daily Updates, ensuring up-to-date and timely coverage of noteworthy ASC industry developments. They also enjoy on-demand, direct access to SmartTRAK expert analysts.

New products and technologies in Shoulder Replacement and the Extremities Fixation Segments planted the seeds for sequential growth in the Q123 Extremities Market

The US Extremities Market grew 7.8% in Q123 with new products and continued recovery of elective procedures encouraging growth despite concerns about a looming recession. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Extremities Market to weather these issues and continue to experience strong growth through 2023.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Extremities Market Recap* are:

• Complete Q123 Extremities Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• New Products and Technologies That are Planting the Seeds for Growth in Shoulders
• Extremities Fixation Closes the Quarter on High with Solid Returns
• Q123 Regulatory Highlights

Both US Extremities Fixation subsegments, Upper Extremities Fixation and Foot Ankle Fixation, ended the first quarter of 2023 with ...

Read the entire Q123 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Total Joints Market Recap* are:

• Complete Q123 Total Joints Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Technologies and Procedure Recovery Elevating Hip Growth
• The Ongoing March Towards Cementless Knees
• Deals and Financing Highlights
• Q123 Regulatory Highlights

Will this momentum continue throughout 2023? SmartTRAK believes underlying demand for hip and knee replacement surgery will ...

Read the entire Q123 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.